Roeland Nusse wins $3 million Breakthrough Prize The developmental biologist was honored for helping to decode how Wnt signaling proteins affect embryonic development, cancer and the activity of tissue-specific adult stem cells that repair damage after injury or disease.

Researchers develop new compound to reduce tumor growth Researchers at Stanford found that a new cell surface receptor they created is effective at inhibiting cancer growth in mice.

Stem cells police themselves to reduce scarring Stem cells produce a decoy protein to attenuate growth signals. Artificially regulating this pathway might help keep muscles supple in muscular dystrophy or during normal aging, researchers hope.

Stanford patient was first to receive lifesaving drug as an infant Four-year-old Zoe Harting is doing well after participating in a phase-2 clinical trial of the first drug for a deadly genetic disease, spinal muscular atrophy type 1.

Study reveals drug interactions that may reduce mortality in breast cancer patients Stanford researchers found that certain drug combinations were associated with lower mortality rates among breast cancer patients, pointing to potential drug targets and new ways of thinking about known diseases.

Study establishes extent of human brain excited by specific dose of electricity Until now, no quantitative relationship between the level of electricity applied to the brain and the extent of neural activity generated has been plotted in humans.